about
Vitamin D and alternative splicing of RNAEpidemiological survey of idiopathic scoliosis and sequence alignment analysis of multiple candidate genes.The association between aortic calcification and fracture risk in postmenopausal women in China: the prospective Chongqing osteoporosis studyUmbilical cord Wharton's jelly repeated culture system: a new device and method for obtaining abundant mesenchymal stem cells for bone tissue engineeringRapid and accurate detection of RMP- and INH- resistant Mycobacterium tuberculosis in spinal tuberculosis specimens by CapitalBio™ DNA microarray: a prospective validation study.Injectable thermosensitive chitosan/β-glycerophosphate/collagen hydrogel maintains the plasticity of skeletal muscle satellite cells and supports their in vivo viability.C/EBPβ mediates osteoclast recruitment by regulating endothelial progenitor cell expression of SDF-1α.Surgical treatment of the osteoporotic spine with bone cement-injectable cannulated pedicle screw fixation: technical description and preliminary application in 43 patientsRepeated microendoscopic discectomy for recurrent lumbar disk herniation.Improved Monosegment Pedicle Instrumentation for Treatment of Thoracolumbar Incomplete Burst Fractures.Two-stage therapeutic utility of ectopically formed bone tissue in skeletal muscle induced by adeno-associated virus containing bone morphogenetic protein-4 geneComparison between the antero-posterior and anterior approaches for treating L5-S1 vertebral tuberculosis.Surgical treatment of lumbosacral tuberculosis by one-stage debridement and anterior instrumentation with allograft through an extraperitoneal anterior approach.CTLA4 enhances the osteogenic differentiation of allogeneic human mesenchymal stem cells in a model of immune activation.Treatment effect, postoperative complications, and their reasons in juvenile thoracic and lumbar spinal tuberculosis surgery.Periostin: A Downstream Mediator of EphB4-Induced Osteogenic Differentiation of Human Bone Marrow-Derived Mesenchymal Stem Cells.Changing expression profiles of lncRNAs, mRNAs, circRNAs and miRNAs during osteoclastogenesisA tissue-engineered subcutaneous pancreatic cancer model for antitumor drug evaluationPrevascularisation with endothelial progenitor cells improved restoration of the architectural and functional properties of newly formed bone for bone reconstructionCordycepin Prevents Bone Loss through Inhibiting Osteoclastogenesis by Scavenging ROS Generation.The outcomes of chemotherapy only treatment on mild spinal tuberculosisDrug susceptibility testing guided treatment for drug-resistant spinal tuberculosis: a retrospective analysis of 19 patients.An anti-infection tissue-engineered construct delivering vancomycin: its evaluation in a goat model of femur defect.Posterior-only spinal fusion without rib head resection for treating type I neurofibromatosis with intra-canal rib head dislocation.Treatment of AO/OTA 31-A3 intertrochanteric femoral fractures with a percutaneous compression plate.A synergistic therapeutic scheme for hyperglycemia and nephrotic disorders in diabetes.DC-STAMP, the key fusion-mediating molecule in osteoclastogenesis.Knockdown of TNFR1 Suppresses Expression of TLR2 in the Cellular Response to Staphylococcus aureus Infection.Improving the osteogenic efficacy of BMP2 with mechano growth factor by regulating the signaling events in BMP pathway.Involvement of toll-like receptor 2 and pro-apoptotic signaling pathways in bone remodeling in osteomyelitis.MicroRNA-24 inhibits osteosarcoma cell proliferation both in vitro and in vivo by targeting LPAATβ.Co-culture with endothelial progenitor cells promotes survival, migration, and differentiation of osteoclast precursors.Vascular endothelial growth factor and physiological compressive loading synergistically promote bone formation of tissue-engineered bone.Vascular endothelial growth factor release from alginate microspheres under simulated physiological compressive loading and the effect on human vascular endothelial cells.HDAC2 regulates FoxO1 during RANKL-induced osteoclastogenesis.The immunomodulatory activity of human umbilical cord blood-derived mesenchymal stem cells in vitro.Tissue-engineered bone treating simple bone cyst--a new strategy.One-Stage Anterior Approach with Arch Plate to Treat Lumbosacral Tuberculosis.Treatment Experiences and Management Outcomes for Skipped Multisegmental Spinal Tuberculosis.Toll-like receptor 2 agonist Pam3CSK4 up-regulates FcεRI receptor expression on monocytes from patients with severe extrinsic atopic dermatitis.
P50
Q27023671-FF95A2FE-3E7E-43FC-A9BF-F08885973510Q30410850-B7A2B4D2-2E9F-4A3E-86E6-0571EB5BBAF5Q33589913-04BE282D-85DF-4D39-B4E9-810CD0E09D7AQ34374384-29773B2A-9551-4519-BA4D-D4A0D1305C1BQ34476709-672F03CD-5748-49CA-BE90-CD3F5BCC73F2Q34688374-E1C552AA-C160-4D3C-BD7F-CE3ECE2DF268Q35117648-15D36E54-BCF3-412D-B9E9-EC7DFDA0C601Q35152592-5582F17E-F3AD-4A77-A26E-A6D5CDEAE11FQ35152596-D81985EC-9A32-4EF1-887C-259864DDC0A5Q35614195-7EB5F1E7-D9EC-42E7-861D-04C9D162E1DAQ35673327-5801D9FF-83E2-4E6D-B989-B2DFB9C7F9ACQ35767021-573A8BB1-FECD-46A1-A7FE-168274D1D381Q35814724-FDB72DBF-1F53-4A43-A555-7D34AF64BAA4Q35881348-335601B0-9A83-4667-A905-FBB60AF5A5E6Q36110759-00467895-B6B3-4150-9C5C-83A317F71720Q36415891-61EAA148-8799-43E7-BAD2-207489B6C2DBQ36560200-A931675B-E72B-40B0-BA8B-2A2A68424114Q36714052-C1CF8E37-588E-4046-8FEE-32B090F57C8FQ36722041-8A3642CD-963B-4BD5-9BD2-34A43EA70F74Q36846350-EE041812-00AE-41B3-9A01-00450BBF99A6Q36903970-D38E33EF-0295-47E2-BFFD-C2F08B804B24Q37044788-44CFCB53-FEE3-4DBD-AD62-EDB6BD74AC29Q37246110-0A8A33D8-2840-4B52-8633-02693800C8A3Q37342524-21E7EA7F-901B-4834-AF2E-16C0059CB094Q37408588-A0EC3966-ED8A-4460-9ABA-8FA945FA9181Q37660802-3C4A3E3E-60A5-4F23-B332-05EA8B769490Q38178193-C92F730C-49D2-4710-8D11-8496DE2BCFDBQ38796460-994779C5-36D6-4D65-8D94-D3CB3B5DE6D5Q38890787-90E0A0F3-E9CF-4337-8F69-846D11764F2CQ38928810-1940A209-A093-4EF4-A79D-8A0A073167C5Q39167853-73A95222-D5EB-4069-8B9B-A5B35ACA452FQ39233562-3BA5050F-BDA7-4E1D-A224-FEE015DB4C97Q39399381-F609B4E7-54F1-4700-861B-6499E7468596Q39780084-7866841C-CABF-46BF-B592-A6EF7F84C825Q39932979-123A9C0F-5FC7-41C3-8E44-EEDD4D0AB59BQ40071382-ECB947F6-245A-414E-AF96-D8A06D417FC7Q40370374-25DACCD9-E349-4200-B2F4-98A2B6D847C4Q40824617-3E69D0FD-DA79-4539-822F-64C8CAA675DEQ40855386-9C7F4906-113E-42B6-B0A3-318281FB04CCQ41285951-7C62DDC4-2BDA-4E04-A0EC-5573471013A2
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Jianzhong Xu
@ast
Jianzhong Xu
@en
Jianzhong Xu
@es
Jianzhong Xu
@nl
Jianzhong Xu
@sl
type
label
Jianzhong Xu
@ast
Jianzhong Xu
@en
Jianzhong Xu
@es
Jianzhong Xu
@nl
Jianzhong Xu
@sl
prefLabel
Jianzhong Xu
@ast
Jianzhong Xu
@en
Jianzhong Xu
@es
Jianzhong Xu
@nl
Jianzhong Xu
@sl
P106
P1153
9245881400
P31
P496
0000-0003-0434-5148